Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

BE/BA studies

Some of the key services that are offered by Triumpharma are Bioequivalence and bioavailability studies that are used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.

Triumpharma has successfully conducted different types of BE/BA clinical trials since 2002. These studies have been performed on both healthy subjects and patients, awith various types of drugs and formulations including: Modified release tablets/capsules, complex injectables, conventional tablets/capsules, creams/lotions/Ointments, Orodispersible tablets (ODT), Inhalers and others dosage forms.

The Studies performed for world global market submission include: Jordan, USA, Europe, Canada and MENA (the Middle East and North Africa) markets.


Phase 1-III and IV clinical trials

Triumpharma is considered one of the leading CRO in the conduct of clinical trials in the region.

Triumpharma has a very strong personal link with specialist physicians who have a previous experience in performing clinical trials.

Main therapeutic area of expertise including but not limited to: Cardiovascular diseases, Gastro-intestinal disorders, pulmonary disorders, metabolic disorders, Endocrinology, Nephrology/Hepatology, Disorders of immune systems, Neurology/Psychiatry, Gynecology, Acute/Chronic infections and Oncology.



This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation